{"id":"CHEMBL1066","canonicalSmiles":"COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1","inchiKey":"TVYLLZQTGLZFBW-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R,R)-TRAMADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rel-Tramadol"],"crossReferences":{"PubChem":["144205141","170464654","26663897","29215256","29215258"],"Wikipedia":["Tramadol"],"drugbank":["DB00193"],"chEBI":["75725"]},"childChemblIds":["CHEMBL1200336","CHEMBL201531","CHEMBL438627","CHEMBL379021"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL114283","canonicalSmiles":"Nc1ccc2c(c1)CN1C(=O)c3ccccc3C1=N2","inchiKey":"SRIOCKJKFXAKHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANIQUIDONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY H 2049","BAY-H-2049","Batracylin","Daniquidone","NSC-320846"],"crossReferences":{"PubChem":["170466457","457170"],"drugbank":["DB12804"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL116018","canonicalSmiles":"O=C(NO)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"JJQQOJRGUHNREK-PWNYCUMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL116018","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1172","canonicalSmiles":"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1","inchiKey":"JAUOIFJMECXRGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESLORATADINE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerius","Clarinex","Desloratadine","Midetorin","Neoclarityn"],"synonyms":["Desloratadine","Loratadine related compound a","Loratadine related compound a rs","SCH 34117","SCH-34117"],"crossReferences":{"DailyMed":["desloratadine"],"PubChem":["144205127","14742700","170464781","26719697","26754458","29215232","50086379"],"Wikipedia":["Desloratadine"],"drugbank":["DB00967"],"chEBI":["291342"]},"count":13,"approvedIndications":["EFO_0005854","EFO_0005531","EFO_0003956","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","HP_0000964","EFO_0000274","EFO_0003060","EFO_0007214","EFO_0005531","Orphanet_79292","MONDO_0002406","EFO_1001871","EFO_0007141","EFO_1001417","EFO_0003785","EFO_0003956"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL1177","canonicalSmiles":"NC1=NC(=O)C(c2ccccc2)O1","inchiKey":"NRNCYVBFPDDJNE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PEMOLINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Canada"," United Kingdom"],"classes":["Hepatotoxicity"],"year":1997},"tradeNames":["Cylert","Pemoline","Ronyl","Tradon","Volital"],"synonyms":["Fenoxazol","LA-956","NSC-169499","NSC-25159","Pemoline","YH-1"],"crossReferences":{"PubChem":["144206062","170465421","26719702"],"TG-GATEs":["51"],"Wikipedia":["Pemoline"],"drugbank":["DB01230"],"chEBI":["7953"]},"count":2,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for attention deficit hyperactivity disorder and has 1 investigational indication. It was withdrawn in Canada and  United Kingdom initially in 1997 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL118902","canonicalSmiles":"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.O=C([O-])C(O)C(O)C(=O)O.O=C([O-])C(O)C(O)C(=O)O","inchiKey":"HSMKTIKKPMTUQH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL118902","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1271","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26748869"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1194","canonicalSmiles":"CCCNC(C)C(=O)Nc1ccccc1C","inchiKey":"MVFGUOIZUNYYSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRILOCAINE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASTRA-1512","ASTRA-1515","Citanest","NSC-40027","Prilocaine","Propitocaine"],"crossReferences":{"DailyMed":["prilocaine","prilocaine%20hydrochloride"],"PubChem":["90341069"],"Wikipedia":["Prilocaine"],"drugbank":["DB00750"],"chEBI":["8404"]},"childChemblIds":["CHEMBL1200586"],"count":4,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0007202","EFO_0000701","EFO_0004616","EFO_0006510","EFO_0000707","EFO_0003843","HP_0000023","MONDO_0002635","EFO_0002496","EFO_0002950"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for pain and has 3 investigational indications."}
{"id":"CHEMBL1200351","canonicalSmiles":"Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Na+]","inchiKey":"JLDCNMJPBBKAHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIAZINE SODIUM","yearOfFirstApproval":1941,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL439","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sulfadiazine sodium"],"synonyms":["Sulfadiazine sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1941."}
{"id":"CHEMBL1200430","canonicalSmiles":"CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12","inchiKey":"FHXBMXJMKMWVRG-SLHNCBLASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL ACETATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Femring","Femtrace"],"synonyms":["E3A","ESTRADIOL-3-ACETATE","Estradiol 3-acetate","Estradiol acetate"],"crossReferences":{"DailyMed":["estradiol%20acetate"],"PubChem":["144204912","170465258"],"drugbank":["DB13952"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200490","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"SBNPWPIBESPSIF-MHWMIDJBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CETRORELIX","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cetrotide"],"synonyms":["Cetrorelix"],"crossReferences":{"DailyMed":["cetrorelix"],"Wikipedia":["Cetrorelix"],"drugbank":["DB00050"],"chEBI":["59224"]},"childChemblIds":["CHEMBL2103735"],"count":5,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","Orphanet_64739","EFO_0000545","EFO_0000731","EFO_0001065","EFO_0000284","EFO_0000660"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 5 investigational indications."}
{"id":"CHEMBL1200608","canonicalSmiles":"CCCCC(CC)COC(=O)/C=C/c1ccc(OC)cc1","inchiKey":"YBGZDTIWKVFICR-JLHYYAGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTINOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212893","29216315"],"Wikipedia":["Octyl_methoxycinnamate"],"drugbank":["DB09496"],"chEBI":["88667"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200733","canonicalSmiles":"FC(F)OC(F)C(F)(F)F","inchiKey":"DPYMFVXJLLWWEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESFLURANE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Suprane"],"synonyms":["Desflurane","I-653"],"crossReferences":{"DailyMed":["desflurane"],"Wikipedia":["Desflurane"],"drugbank":["DB01189"],"chEBI":["4445"]},"count":2,"linkedTargets":{"rows":["ENSG00000169427","ENSG00000109158","ENSG00000145863","ENSG00000082482","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000186795","ENSG00000171303","ENSG00000094755","ENSG00000145888","ENSG00000100433","ENSG00000163285","ENSG00000113327","ENSG00000268089","ENSG00000186297","ENSG00000163288"],"count":22},"linkedDiseases":{"rows":["MONDO_0018373","EFO_0005323","EFO_1001905","EFO_0004278","EFO_0000266","EFO_1001311","EFO_0001073","EFO_1002048","EFO_0002615","HP_0000713","EFO_0002506","EFO_0003884","EFO_0004888","EFO_1001250"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 2 investigational indications."}
{"id":"CHEMBL1200782","canonicalSmiles":"C[C@H](N)Cc1ccccc1.O=C(O)CCCCC(=O)O","inchiKey":"OFCJKOOVFDGTLY-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROAMPHETAMINE ADIPATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL612","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dextroamphetamine adipate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975."}
{"id":"CHEMBL1200978","canonicalSmiles":"O=[As]O[As]=O","inchiKey":"IKWTVSLWAPBBKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARSENIC TRIOXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Trisenox"],"synonyms":["Arsenic trioxide"],"crossReferences":{"PubChem":["26758061"],"Wikipedia":["Arsenic_trioxide"],"drugbank":["DB01169"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201075","canonicalSmiles":"CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"UUMLTINZBQPNGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOXILAN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxilan","Oxilan-300","Oxilan-350"],"synonyms":["Ioxilan"],"crossReferences":{"PubChem":["144206678","170465160"],"Wikipedia":["Ioxilan"],"drugbank":["DB09135"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995."}
{"id":"CHEMBL1201085","canonicalSmiles":"Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N.O","inchiKey":"WDZJJRLYFQNCQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1201085","maximumClinicalTrialPhase":0,"parentId":"CHEMBL945","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49681635"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201113","canonicalSmiles":"Cl.O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"CUSPGNDCPOVPBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETIRIZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1000","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14743457"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201118","canonicalSmiles":"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+]","inchiKey":"BITQGIOJQWZUPL-PBCQUBLHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMETAZOLE SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201195","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zefazone"],"synonyms":["Cefmetazole sodium","Cefmetazole sodium salt","U-72791A"],"crossReferences":{"PubChem":["170465052","50106019","855824"],"chEBI":["3490"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and has 1 investigational indication."}
{"id":"CHEMBL1201236","canonicalSmiles":"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O","inchiKey":"TZFNLOMSOLWIDK-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIDOPA","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lodosyn"],"synonyms":["Carbidopa"],"crossReferences":{"DailyMed":["carbidopa"],"PubChem":["11113507","144204461","26749935","29215028","50104417","50104418","8139862","93576631"],"Wikipedia":["Carbidopa"],"drugbank":["DB00190"],"chEBI":["39585"]},"childChemblIds":["CHEMBL1200748"],"linkedTargets":{"rows":["ENSG00000132437"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002610","EFO_0005687","EFO_0001365","EFO_0002508","EFO_1000809","EFO_0005252","EFO_1001919","MONDO_0001020","EFO_0003768","Orphanet_55","HP_0002381","HP_0003418","Orphanet_72","EFO_0003843","EFO_0000537","Orphanet_791","EFO_0003885","EFO_1001175","Orphanet_1764","MONDO_0002050","EFO_0000270","EFO_0000712","EFO_1001402","EFO_0000253","MONDO_0001162","EFO_0000692"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975."}
{"id":"CHEMBL1201314","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)[nH]c(N)nc21","inchiKey":"WPVFJKSGQUFQAP-GKAPJAKFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALGANCICLOVIR","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Valganciclovir"],"crossReferences":{"DailyMed":["valganciclovir%20hydrochloride"],"Wikipedia":["Valganciclovir"],"drugbank":["DB01610"],"chEBI":["63635"]},"childChemblIds":["CHEMBL1200454"],"count":13,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for viral disease and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201325","canonicalSmiles":"C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1","inchiKey":"ZRYHPQCHHOKSMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOCYCLIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexocyclium"],"crossReferences":{"Wikipedia":["Hexocyclium"],"drugbank":["DB06787"],"chEBI":["5707"]},"childChemblIds":["CHEMBL1626570"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201458","drugType":"Small molecule","blackBoxWarning":true,"name":"ETHIODIZED OIL","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethiodol","Lipiodol"],"synonyms":["Ethiodized oil"],"crossReferences":{"DailyMed":["ethiodized%20oil"],"Wikipedia":["Lipiodol"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201608","drugType":"Antibody","blackBoxWarning":true,"name":"MUROMONAB-CD3","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orthoclone okt3"],"synonyms":["L04AA02","Muromonab cd3","Muromonab-cd3","OKT-3","OKT3"],"crossReferences":{"DrugCentral":["5177"],"Wikipedia":["Muromonab-CD3"]},"count":10,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000729","EFO_0003865","EFO_0000389","EFO_0000756","EFO_1001249","MONDO_0002367","EFO_0000540","EFO_0000311","EFO_1000158"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for immune system disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201759","canonicalSmiles":"O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1.O=S(=O)(O)c1ccccc1","inchiKey":"UDGHXQPQKQPSBB-BOXHHOBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPOTASTINE BESYLATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201758","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bepreve"],"synonyms":["BB","Bepotastine Besilate","Bepotastine benzenesulfonate salt","Bepotastine besilate","Bepotastine besylate","TAU-284"],"crossReferences":{"DailyMed":["bepotastine%20besilate"],"chEBI":["31281"]},"count":3,"approvedIndications":["EFO_0007141"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0007141","EFO_1001417","EFO_0003785"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for allergic conjunctivitis and has 2 investigational indications."}
{"id":"CHEMBL1213528","canonicalSmiles":"C/C=C/C(=O)O","inchiKey":"LDHQCZJRKDOVOX-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROTONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crotonate","Crotonic Acid"],"crossReferences":{"Wikipedia":["Crotonic_acid"],"drugbank":["DB02074"],"chEBI":["41131"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230661","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](Oc2ccccc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C","inchiKey":"QKPXPZYQPBWDHS-MCJAPYMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04612"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12315","canonicalSmiles":"c1ccc2cnccc2c1","inchiKey":"AWJUIBRHMBBTKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOQUINOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Benzanine"],"crossReferences":{"PubChem":["144212820"],"Wikipedia":["Isoquinoline"],"drugbank":["DB04329"],"chEBI":["16092"]},"childChemblIds":["CHEMBL328754"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232595","canonicalSmiles":"C=Cc1ccc(O)c(OC)c1","inchiKey":"YOMSJEATGXXYPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232595","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["251919945"],"drugbank":["DB03514"],"chEBI":["42438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232920","canonicalSmiles":"O=P(O)(O)OC[C@H](O)CO","inchiKey":"AWUCVROLDVIAJX-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232920","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29218087"],"drugbank":["DB02515"],"chEBI":["15978"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232997","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CSc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)NCC(=O)O)C(=O)O","inchiKey":"FXEUKVKGTKDDIQ-UWVGGRQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232997","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02458"],"chEBI":["8927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233636","canonicalSmiles":"O=S(=O)(O)Oc1c[nH]c2ccccc12","inchiKey":"BXFFHSIDQOFMLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOXYL SULFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07992"],"chEBI":["43355"]},"childChemblIds":["CHEMBL1452061"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234254","canonicalSmiles":"Cc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"SJXRKKYXNZWKDB-DJLDLDEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234254","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03735"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234635","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)NCB(O)O","inchiKey":"VGXJNGVFESCMME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234635","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02841"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235259","canonicalSmiles":"OCCOCCOCCO","inchiKey":"ZIBGPFATKBEMQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIETHYLENE GLYCOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205626","144209638","144210626","26757203","26757204"],"drugbank":["DB02327"],"chEBI":["44926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236200","canonicalSmiles":"CC(C)(C)OC=O","inchiKey":"RUPAXCPQAAOIPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERT-BUTYL FORMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207557","17388715"],"drugbank":["DB02768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237065","canonicalSmiles":"COc1cccc(C2(O)CCCCC2CN(C)C)c1.Cl","inchiKey":"PPKXEPBICJTCRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAMADOL HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237044","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aceon","Conzip","Dromadol sr","Dromadol xl","Invodol sr","Larapam sr","Mabron","Maneo","Marol","Maxitram sr","Nobligan ret","Oldaram","Rybix odt","Ryzolt","Tilodol sr","Tradorec xl","Tramacet","Tramadol hydrochloride","Tramake","Tramake insts","Tramquel sr","Tramulief sr","Ultram","Ultram er","Zamadol","Zamadol 24hr","Zamadol melt","Zamadol sr","Zeridame sr","Zydol","Zydol sr","Zydol xl"],"synonyms":["CG-315","CG-315E","NIH-10969","Tramadol hydrochloride","Tramadol hydrochloride civ","U-26,225A","U-26225A"],"crossReferences":{"DailyMed":["tramadol%20hydrochloride"]},"count":4,"approvedIndications":["HP_0012532","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0002506","HP_0012532","EFO_0004253","EFO_0010072","HP_0003419","EFO_0003843","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for chronic pain and pain and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1256285","canonicalSmiles":"Cc1cn[nH]c1.Cl","inchiKey":"PUCXJHNDMYZOHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Methylpyrazole HCl","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1308","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methylpyrazole HCl"],"crossReferences":{"PubChem":["170465026","50106543","57260551"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL129","canonicalSmiles":"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"HBOMLICNUCNMMY-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIDOVUDINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["AZT","Azidothymidine","Retrovir","Zidovudine"],"synonyms":["AZT","Azidothymidine","BW A509U","BW-A-509U","BW-A509U","BWA509U","COMPOUND S","COMPOUND-S","NSC-602670","Retrovir","Zidovudine"],"crossReferences":{"DailyMed":["zidovudine"],"PubChem":["144203613","144204445","144209401","144210895","170464737","17390027","26751584","49718184","855980","90341185"],"Wikipedia":["Zidovudine"],"drugbank":["DB00495"],"chEBI":["10110"]},"count":20,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1295","canonicalSmiles":"Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1","inchiKey":"SWLMUYACZKCSHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTOCONAZOLE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butoconazole","Gynazole-1"],"crossReferences":{"Wikipedia":["Butoconazole"],"drugbank":["DB00639"],"chEBI":["3240"]},"childChemblIds":["CHEMBL1200398"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL131921","canonicalSmiles":"COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1","inchiKey":"WUADCCWRTIWANL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIOCHANIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-123538"],"crossReferences":{"PubChem":["11113288","124883150","124883151","144209295","144213218","174007208","26746976","26751494","416963","50100559","50104034","50123128","56422868","855738"],"Wikipedia":["Biochanin_A"],"drugbank":["DB15334"],"chEBI":["17574"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1325592","canonicalSmiles":"C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)c(C)c3C=C","inchiKey":"KSFOVUSSGSKXFI-UJJXFSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOPORPHYRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111672","124881200","26747639","29218041","50106857","85231196","90341512"],"drugbank":["DB02285"],"chEBI":["15430"]},"childChemblIds":["CHEMBL2105866"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330113","canonicalSmiles":"Cl.N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1","inchiKey":"AVRXPIQGQAHQTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1330113","maximumClinicalTrialPhase":0,"parentId":"CHEMBL790","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50085976","56314762","56320768","56323659"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1373254","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O","inchiKey":"BKYKPTRYDKTTJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTHIAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navidrex"],"synonyms":["Cyclopenthiazide","SU-8341"],"crossReferences":{"PubChem":["170466046","26664668"],"drugbank":["DB13532"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL147507","canonicalSmiles":"Cc1cccc(C)c1OC[C@@H](C)N","inchiKey":"VLPIATFUUWWMKC-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-MEXILETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["mexiletine"],"crossReferences":{"drugbank":["DB07129"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1476782","canonicalSmiles":"COc1ccc(/C=C/C(=O)OCCC(C)C)cc1","inchiKey":"UBNYRXMKIIGMKK-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMILOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amiloxate","E-1000","Isoamyl methoxycinnamate"],"crossReferences":{"PubChem":["29215376"],"drugbank":["DB11207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL148630","canonicalSmiles":"O=Cc1ccccc1OP(=O)(O)OCc1ccccc1","inchiKey":"PWDTUFYQEUEVQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Phosphoric Acid Benzyl Ester 2-Formyl-Phenyl Ester","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphoric Acid Benzyl Ester 2-Formyl-Phenyl Ester"],"crossReferences":{"drugbank":["DB03078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1526084","canonicalSmiles":"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1.Cl.Cl","inchiKey":"RJNSNFZXAZXOFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANOLAZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1404","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RS-43285","Ranolazine hydrochloride"],"crossReferences":{"PubChem":["50106963"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1571863","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1","inchiKey":"MPIPASJGOJYODL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOCONAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Travogyn"],"synonyms":["Isoconazole","Isoconazole nitrate","R-15,454 [AS NITRATE SALT]"],"crossReferences":{"PubChem":["144204167","170466012","56463710"],"drugbank":["DB08943"],"chEBI":["83667"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1620875","canonicalSmiles":"CCN(CC)CCc1nc(-c2ccccc2)no1","inchiKey":"IDCHQQSVJAAUQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXOLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-438 FREE BASE","AF-438 [AS CITRATE]","Oxolamine","SKF 9976 FREE BASE","SKF 9976 [AS CITRATE]","SKF-9976 FREE BASE"],"crossReferences":{"Wikipedia":["Oxolamine"],"drugbank":["DB13216"]},"childChemblIds":["CHEMBL1448044"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1642","canonicalSmiles":"CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1","inchiKey":"YLMAHDNUQAMNNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMATINIB MESYLATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL941","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gleevec","Glivec","Imatinib mesylate"],"synonyms":["Gleevec","Imatinib mesilate","Imatinib mesylate","Imatinib methanesulfonate","STI 571","STI-571","STI571"],"crossReferences":{"DailyMed":["imatinib%20mesylate"],"PubChem":["144205237","170465393","49681833"],"chEBI":["31690"]},"count":74,"approvedIndications":["EFO_0000339"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000113721","ENSG00000157404"],"count":3},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0001361","EFO_0004683","EFO_0000756","MONDO_0000956","EFO_1000657","EFO_0005952","EFO_0000333","EFO_1001951","EFO_0000565","EFO_0000339","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_1001814","EFO_0000760","MONDO_0002715","EFO_0002618","MONDO_0007608","MONDO_0005149","MONDO_0013730","EFO_0000220","MONDO_0002108","MONDO_0008170","Orphanet_636","EFO_1001946","EFO_0002429","MONDO_0008315","Orphanet_398934","EFO_0000270","MONDO_0044917","EFO_0001359","EFO_0002428","EFO_0000574","EFO_1000613","EFO_0001376","Orphanet_232","MONDO_0015686","EFO_0000768","EFO_1001465","MONDO_0007254","EFO_0000209","MONDO_0021063","MONDO_0002087","MONDO_0003541","HP_0001880","Orphanet_538","EFO_0002430","MONDO_0001056","MONDO_0002158","Orphanet_31112","EFO_0004289","EFO_0000673","EFO_1001361","EFO_1001993","MONDO_0020743","EFO_0000717","MONDO_0002618","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0006859","EFO_0000503","Orphanet_44890","MONDO_0016586","MONDO_0000870","EFO_0000222","EFO_0000313","EFO_0003060","MONDO_0003865","EFO_0000311","EFO_0003885","EFO_1001471","MONDO_0002676","EFO_0000658","EFO_0006861","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","EFO_1001467","MONDO_0024880","EFO_0000691","EFO_0000519","Orphanet_31837"],"count":85},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for chronic myelogenous leukemia and has 73 investigational indications."}
{"id":"CHEMBL1740065","canonicalSmiles":"CCC(C)(CN(C)C)OC(=O)c1ccccc1","inchiKey":"FDMBBCOBEAVDAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMYLOCAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amylocaine"],"crossReferences":{"drugbank":["DB09088"],"chEBI":["34981"]},"childChemblIds":["CHEMBL1718204"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743001","drugType":"Antibody","blackBoxWarning":false,"name":"CIXUTUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cixutumumab","IMC-A12","NSC-742460"],"count":26,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0006859","EFO_0000637","EFO_0000437","EFO_0000756","EFO_0000248","EFO_0000571","MONDO_0007254","EFO_1000657","EFO_1001968","MONDO_0021063","MONDO_0021038","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_1001951","EFO_0000311","EFO_0000588","EFO_0006861","MONDO_0008903","EFO_0000182","EFO_0000673","EFO_0000702","EFO_1000796","EFO_0003050","EFO_0000181"],"count":27},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 26 investigational indications."}
{"id":"CHEMBL1743055","drugType":"Antibody","blackBoxWarning":false,"name":"PANOBACUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AERUMAB 11","Panobacumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743072","drugType":"Antibody","blackBoxWarning":false,"name":"SOLANEZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2062430","LY2062430","Solanezumab"],"count":2,"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["HP_0100543","EFO_0000249"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743077","drugType":"Antibody","blackBoxWarning":false,"name":"TENATUMOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST-2146","Tenatumomab"],"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["MONDO_0044334","EFO_0003863","EFO_0003869","MONDO_0020641","EFO_0003860","EFO_0004284","EFO_0004198","EFO_0005952"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1770248","canonicalSmiles":"CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1","inchiKey":"MCIACXAZCBVDEE-CUUWFGFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTUGLIFLOZIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Steglatro"],"synonyms":["Ertugliflozin","PF-04971729","PF-04971729-00","PF04971729"],"crossReferences":{"DailyMed":["ertugliflozin"],"drugbank":["DB11827"]},"childChemblIds":["CHEMBL3526992"],"count":2,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0001360","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for diabetes mellitus and type ii diabetes mellitus."}
{"id":"CHEMBL178459","canonicalSmiles":"Cc1c(-c2cnccn2)ssc1=S","inchiKey":"CKNAQFVBEHDJQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLTIPRAZ","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-347901","Oltipraz"],"crossReferences":{"PubChem":["462739"],"Wikipedia":["Oltipraz"],"drugbank":["DB12539"],"chEBI":["77319"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1828820","canonicalSmiles":"c1cc([C@H]2CC[C@]3(CC2)OO[C@]2(O3)C3CC4CC(C3)CC2C4)ccc1OCCN1CCOCC1","inchiKey":"XLCNVWUKICLURR-NTNLSYPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEFENOMEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Artefenomel","OZ-439","OZ439","Oz439"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL189434","canonicalSmiles":"OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12","inchiKey":"UQHINZSKNAAVOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL189434","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08393"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190412","canonicalSmiles":"COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/CCCCCCOc2ccc(Cl)cc2)NC#N)cc1.[Cl-]","inchiKey":"DAHMXVAETAAQOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGLARINAD CHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1181731","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EB-1627","EB1627","GMX-1777","GMX1777","Teglarinad chloride"],"count":1,"linkedTargets":{"rows":["ENSG00000105835"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL191482","canonicalSmiles":"CC(C)[C@H](C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1","inchiKey":"LAMIXXKAWNLXOC-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-42","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-HDAC 42","(S)-HDAC-42","AR-42","AR42","Ar-42"],"crossReferences":{"drugbank":["DB12707"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL194176","canonicalSmiles":"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1","inchiKey":"HTIZPBXCJPQDEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194176","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07334"]},"childChemblIds":["CHEMBL193849"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950651","canonicalSmiles":"COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@H](C(=O)NC5CC5)[C@@H](O)[C@H]4O)c3n2)CC1","inchiKey":"SQJXTUJMBYVDBB-RQXXJAGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVODENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atl313, de-112"],"synonyms":["ATL-313","ATL313","Atl313","DE-112","Evodenoson"],"crossReferences":{"drugbank":["DB12295"]},"count":2,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL200528","canonicalSmiles":"CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1","inchiKey":"IVUBNTNWKIPCPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200528","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04715"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2017974","canonicalSmiles":"Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1","inchiKey":"CWHUFRVAEUJCEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUPARLISIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BKM-120","BKM-120NX","BKM120-NX","Bkm-120","Buparlisib","NVP-BKM-120","NVP-BKM120"],"crossReferences":{"PubChem":["137275918"],"drugbank":["DB11666"],"chEBI":["71954"]},"childChemblIds":["CHEMBL2364604"],"count":26,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","MONDO_0044903","EFO_0000756","MONDO_0007254","EFO_1001469","EFO_1001951","EFO_0000565","EFO_1001480","MONDO_0002974","MONDO_0008903","EFO_0000616","EFO_0006859","MONDO_0002108","Orphanet_44890","EFO_0000403","MONDO_0007576","MONDO_0008315","EFO_0003060","EFO_1000581","EFO_0000095","MONDO_0011962","EFO_0001421","EFO_0000702","EFO_0006544","MONDO_0018906","EFO_0000181","EFO_0000519"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 26 investigational indications."}
{"id":"CHEMBL207456","canonicalSmiles":"[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1","inchiKey":"ZQAQXZBSGZUUNL-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITTSBURGH COMPOUND B","maximumClinicalTrialPhase":0,"parentId":"CHEMBL93124","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PIB C-11","Pittsburgh compound b"],"crossReferences":{"drugbank":["DB15161"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2096656","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM TC 99M PENTETATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110551","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["An-dtpa","Draximage dtpa","Dtpa","Mpi dtpa kit - chelate","Tc 99m dtpa kit (chelate)","Techneplex","Technetium tc-99m pentetate kit"],"synonyms":["Human serum albumin diethylenetriaminepentaacetic acid technetium (99mtc) injection","Technetium (99mtc) pentetic acid","Technetium tc 99m pentetate","Technetium tc 99m pentetate sodium","Technetium tc-99m pentetate kit"],"crossReferences":{"DailyMed":["technetium%20tc-99m%20pentetate%20kit"],"DrugCentral":["5096"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2103825","canonicalSmiles":"CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1","inchiKey":"MVCQKIKWYUURMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETILISTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATL-962","Cetilistat"],"crossReferences":{"drugbank":["DB06586"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103826","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O","inchiKey":"DWLTUUXCVGVRAV-XWRHUKJGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DAVUNETIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-108","AL-208","Davunetide"],"crossReferences":{"drugbank":["DB12613"]},"count":3,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["HP_0100543","Orphanet_683","EFO_0000692"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104168","canonicalSmiles":"CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1CC","inchiKey":"ODEGQXRCQDVXSJ-RHSMWYFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMEPRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Betameprodine","NU-1932"],"crossReferences":{"drugbank":["DB01552"]},"childChemblIds":["CHEMBL3246684"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104266","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C(=O)N2[C@H]1C(=O)O","inchiKey":"RPBAFSBGYDKNRG-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dexacillin"],"synonyms":["Epicillin","SQ 11,302"],"crossReferences":{"drugbank":["DB13300"],"chEBI":["58974"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104856","canonicalSmiles":"Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(S(=O)(=O)C(F)(F)F)cc1","inchiKey":"VBUNOIXRZNJNAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PONAZURIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ponazuril"],"crossReferences":{"PubChem":["144206941"],"drugbank":["DB11452"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104988","canonicalSmiles":"CCCc1c(SCCCOc2ccc(C(C)=O)c(OCCCC(=O)O)c2CCC)ccc(C(C)=O)c1O","inchiKey":"KPWYNAGOBXLMSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPELUKAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KCA-757","MN-001","Tipelukast"],"crossReferences":{"drugbank":["DB12435"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105148","canonicalSmiles":"CC1(CCN2CCCCC2)C(=O)CCc2ccccc21","inchiKey":"RVXGRCNWGOHSDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEPINALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nepinalone"],"crossReferences":{"drugbank":["DB13445"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105291","canonicalSmiles":"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CC=C4C=C(OC5CCCC5)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"FLGJKPPXEKYCBY-AKCFYGDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINGESTANOL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quingestanol","Quingestanol acetate","W 4540"],"crossReferences":{"drugbank":["DB14679"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105527","canonicalSmiles":"CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21","inchiKey":"IQWYAQCHYZHJOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"year":2013},"tradeNames":[],"synonyms":["CB 4261","Tetrazepam"],"crossReferences":{"drugbank":["DB13324"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in European Union  in 2013."}
{"id":"CHEMBL2105629","canonicalSmiles":"CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"YIHUEPHBPPAAHH-PEPODRRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINFLUNINE DITARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110725","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Javlor"],"synonyms":["BMS-710485","F-12158","Vinflunine ditartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105741","canonicalSmiles":"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1.C[S+](C)[O-]","inchiKey":"OQUFJVRYDFIQBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAMETINIB DIMETHYL SULFOXIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mekinist"],"synonyms":["GSK-1120212B","GSK1120212B","Trametinib dimethyl sulfoxide"],"crossReferences":{"DailyMed":["trametinib%20dimethyl%20sulfoxide"],"chEBI":["75991"]},"count":4,"approvedIndications":["EFO_0000389","EFO_0002617"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000389","EFO_1000926","EFO_0001378","EFO_0002617","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for metastatic melanoma and cutaneous melanoma and has 2 investigational indications."}
{"id":"CHEMBL2105953","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cn3nnc(C)n3)CS[C@H]12)c1csc(N)n1","inchiKey":"XSPUSVIQHBDITA-RKYNPMAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTERAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefteram","Cefteram pivoxil"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106050","canonicalSmiles":"N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.Nc1ccc(P(=O)(O)O)cc1.Nc1ccc(P(=O)(O)O)cc1","inchiKey":"NSCOCGOFKMUTMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE PHOSPHANILATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL790","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMY-30120","CHP","Chlorhexidine phosphanilate","WP-973"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106825","canonicalSmiles":"CC(=O)[C@@]1(C)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"HCFSGRMEEXUOSS-JXEXPEPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDROGESTONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colpro"],"synonyms":["AY-62022","Medrogestone"],"crossReferences":{"drugbank":["DB09124"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106905","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](C[131I])C4=C(CC[C@H](O)C4)[C@H]3CC[C@@]21C","inchiKey":"QJHZPCLORSPENH-DRTKWHMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORCHOLESTENOL IODOMETHYL (131I) [INJECTION]","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110976","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norcholestenol iodomethyl (131i) [injection]"],"crossReferences":{"drugbank":["DB13487"],"chEBI":["34893"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107583","canonicalSmiles":"O=[N+]([O-])OC[C@H](O[N+](=O)[O-])[C@@H](CO[N+](=O)[O-])O[N+](=O)[O-]","inchiKey":"SNFOERUNNSHUGP-ZXZARUISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHRITYL TETRANITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cardilate"],"synonyms":["Eritrityl tetranitrate","Erythrityl tetranitrate","Erythrol tetranitrate","Tetranitrol"],"crossReferences":{"drugbank":["DB01613"],"chEBI":["60072"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108292","drugType":"Protein","blackBoxWarning":false,"name":"EPTACOG ALFA PEGOL (ACTIVATED)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Activated recombinant human factor vii, long acting","Eptacog alfa pegol (activated)"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108609","drugType":"Unknown","blackBoxWarning":false,"name":"INALIMAREV (CEA, MUC-1, VACCINIA VIRUS)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panvac"],"synonyms":["Inalimarev (cea, muc-1, vaccinia virus)"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108670","drugType":"Antibody","blackBoxWarning":false,"name":"BEZLOTOXUMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mdx-1388","Zinplava"],"synonyms":["Bezlotoxumab","MBL-CDB1","MDX-1388","MK-6072","Mk-6072"],"crossReferences":{"DailyMed":["bezlotoxumab"],"DrugCentral":["5186"]},"count":2,"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 2 investigational indications."}
{"id":"CHEMBL2108720","drugType":"Antibody","blackBoxWarning":false,"name":"OXELUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUMAB OX-40L","HUMAB OX40L","OX-40L","OX40L","Oxelumab","R-4930","R-4930 HUMAB OX40L","R-4930 HUMABOX40L","R4930","RO-49-89991","RO-4989991","RO4989991"],"count":1,"linkedTargets":{"rows":["ENSG00000117586"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108744","drugType":"Unknown","blackBoxWarning":false,"name":"SODIUM ALGINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Algin","E-401","FEMA NO. 2014","INS NO.401","INS-401","Polyelectrolyte 211","Sodium alginate"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109016","drugType":"Unknown","blackBoxWarning":false,"name":"ALUMINUM CHLOROHYDRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hyperdrol"],"synonyms":["Aluminium chlorohydrate","Aluminum chlorhydroxide","Aluminum chlorohydrate","Aluminum hydroxychloride"],"crossReferences":{"DrugCentral":["4495"]},"count":1,"approvedIndications":["EFO_0004260"],"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for bone disease."}
{"id":"CHEMBL2109152","drugType":"Small molecule","blackBoxWarning":false,"name":"MINERAL OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alpha keri","Ashbourne emollient","Aveeno","Balneol","Dermalo","Doublebase","Emmolate","Emulsiderm","Gppe emollient","Lacri-lube","Liq paraf light","Lubri-tears","Neo-cultol","Nujol","Oilatum jnr","Petrolagar","Rae's","Zerolatum","Zerolatum plus"],"synonyms":["E-905D","INS NO.905D","INS-905D","Liquid paraffin","Mineral oil","Paraffin, liquid","Petrolatum, liquid"],"count":2,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL2109201","drugType":"Unknown","blackBoxWarning":false,"name":"MUMPS VIRUS VACCINE LIVE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mumpsvax"],"synonyms":["Mumps vaccine","Mumps virus vaccine live","Mumps, live attenuated"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109337","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-1342","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1342","Mdx-1342"],"count":2,"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000095"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109467","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-714","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 714","AMG-714","Amg-714","PRV-015"],"count":4,"linkedTargets":{"rows":["ENSG00000164136"],"count":1},"linkedDiseases":{"rows":["EFO_0001060","EFO_0000685","EFO_0000676","EFO_0004208"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109485","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN CD6","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN CD6"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110731","canonicalSmiles":"CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1","inchiKey":"VWVKUNOPTJGDOB-BDHVOXNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFOGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tofogliflozin"],"crossReferences":{"drugbank":["DB11824"]},"childChemblIds":["CHEMBL2105711"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL218291","canonicalSmiles":"O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12","inchiKey":"IWKXDMQDITUYRK-KUBHLMPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORODESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fodosine"],"synonyms":["BCX-1777","Forodesine"],"crossReferences":{"Wikipedia":["Forodesine"],"drugbank":["DB06185"],"chEBI":["43362"]},"childChemblIds":["CHEMBL550755","CHEMBL1213652"],"count":5,"linkedTargets":{"rows":["ENSG00000198805"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000095","EFO_0002913","EFO_0004289","EFO_0000574","EFO_0000094","EFO_0000311","MONDO_0000430"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL223402","canonicalSmiles":"O=C(Nc1ccccc1F)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O","inchiKey":"MTPVBMVUENFFLL-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RSV-604","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-60444","RSV 604","RSV-604","RSV604","Rsv-604","Rsv604"],"crossReferences":{"drugbank":["DB15197"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2386889","canonicalSmiles":"Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1","inchiKey":"GMIZZEXBPRLVIV-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-900776","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8776","SCH 900776","SCH-900776","Sch-900776"],"crossReferences":{"drugbank":["DB11899"]},"count":5,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000220","EFO_0000222","EFO_0000183","EFO_0005952"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL249334","canonicalSmiles":"Cc1ccccc1-c1cc(NCc2ccc[n+]([O-])c2)n2ncc(Br)c2n1","inchiKey":"DXUJQXZHHGJMFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL249334","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255874","canonicalSmiles":"Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2","inchiKey":"PNEWIQAEGKQNCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255874","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258467","canonicalSmiles":"Cc1cc(-c2csc(Nc3ccc(C(=O)O)c(O)c3)n2)ccc1F","inchiKey":"LKZZDHKJFDTYCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL258467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269521","canonicalSmiles":"Clc1cncc(N2CCNCC2)n1","inchiKey":"CJAWPFJGFFNXQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-212","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-212"],"crossReferences":{"PubChem":["11113807","26751984"],"drugbank":["DB12111"]},"childChemblIds":["CHEMBL3250751"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278519","canonicalSmiles":"O=C1c2ccccc2C(=O)C1c1ccc(Cl)cc1","inchiKey":"NJDUWAXIURWWLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORINDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlophenadione","Chlorphenindione","Chlorphenylindandione","Clorindione","G-25766"],"crossReferences":{"PubChem":["144205450","29216241","50085911"],"Wikipedia":["Clorindione"],"drugbank":["DB13275"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL289480","canonicalSmiles":"C1COC(NC(C2CC2)C2CC2)=N1","inchiKey":"CQXADFVORZEARL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILMENIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rilmenidine"],"crossReferences":{"PubChem":["104171229","11111726","11111727","11113329","124881316","144203805","170466278","50103956","510678","85231209","90340708"],"Wikipedia":["Rilmenidine"],"drugbank":["DB11738"],"chEBI":["8862"]},"childChemblIds":["CHEMBL1256674"],"count":1,"linkedTargets":{"rows":["ENSG00000010322"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL292376","canonicalSmiles":"COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1","inchiKey":"ZVQUCWXZCKWZBP-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECALCET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tecalcet"],"childChemblIds":["CHEMBL2107572"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL301769","canonicalSmiles":"Nc1nc(N)c2nc(CN3c4ccccc4C=Cc4ccccc43)cnc2n1","inchiKey":"NXCCIJQEAKMFGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL301769","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08406"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305178","canonicalSmiles":"C[C@H](Nc1nccc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)n1)c1ccccc1","inchiKey":"QICPQLFMWYQJGX-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL305178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01761"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3109319","canonicalSmiles":"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2.O","inchiKey":"XOQNJTMQFFAIPP-MZMZDCEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3109319","maximumClinicalTrialPhase":0,"parentId":"CHEMBL450895","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3125318","canonicalSmiles":"[2H][C@@]1(c2ccc(Cl)c(Cc3ccc(OCC)cc3)c2)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"JVHXJTBJCFBINQ-KMPNWDRBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3125318","maximumClinicalTrialPhase":0,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137303","canonicalSmiles":"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)([O-])[O-])c2)c(OC)c1.[Na+].[Na+]","inchiKey":"MIBWXNAYNGADJD-MIIBGCIDSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BRICICLIB SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1206245","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Briciclib sodium","ON 013105"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137322","canonicalSmiles":"O[C@H]([C@@H]1CO1)[C@@H](O)[C@H]1CO1","inchiKey":"AAFJXZWCNVJTMK-GUCUJZIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIANHYDROGALACTITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dianhydrogalactitol","NSC-132313","NSC-1323313","VAL-083"],"crossReferences":{"drugbank":["DB12873"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3137329","canonicalSmiles":"Br.NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2CC3C[C@@H]1C[C@](O)(C3)C2","inchiKey":"ZUVPMAPXNYGJQC-NUHVQPJCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFICITINIB HYDROBROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3137308","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP015K hydrobromide","Peficitinib hydrobromide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137332","canonicalSmiles":"Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F","inchiKey":"GFPPXZDRVCSVNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEVIPIPRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fevipiprant","NVP-QAW039","QAW-039","QAW039"],"crossReferences":{"drugbank":["DB12011"]},"count":7,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000083","EFO_0000270","EFO_0001421","EFO_0000341","EFO_0000274","HP_0001880"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL318721","canonicalSmiles":"CCC(CC)n1ccc2c3c(N)nc(N)nc3ccc21","inchiKey":"GCPJCLJGTVTGRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL318721","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07862"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301614","canonicalSmiles":"Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1.Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"FWIDBLDKHORZBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOREFORANT TARTRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301609","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-38518168","JNJ-38518168 HEMITARTRATE","Toreforant tartrate"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3301673","canonicalSmiles":"CCCCCNC(=O)c1coc([C@@H]2[C@H]3CC[C@H](O3)[C@@H]2Cc2ccccc2CCC(=O)O)n1","inchiKey":"BBPRUNPUJIUXSE-DXKRWKNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IFETROBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-180291","Ifetroban"],"crossReferences":{"drugbank":["DB12321"]},"childChemblIds":["CHEMBL3301674"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL332750","canonicalSmiles":"CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC","inchiKey":"XDBHURGONHZNJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETOMILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OPC-6535","Tetomilast"],"crossReferences":{"drugbank":["DB05298"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3330226","canonicalSmiles":"O=c1nc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12","inchiKey":"BJDZBXGJNBMCAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACOZINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Macozinone","PBTZ-169","PBTZ169"],"crossReferences":{"drugbank":["DB14821"]},"childChemblIds":["CHEMBL4521338"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL33720","canonicalSmiles":"CNCC(O)c1ccc(O)cc1","inchiKey":"YRCWQPVGYLYSOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxedrine","Synephrine"],"crossReferences":{"PubChem":["144203941","144208160","170466681","17388717","174007352","49681813","50105255","85231217","855689","90340909"],"Wikipedia":["Synephrine"],"drugbank":["DB09203"],"chEBI":["29081"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL345714","canonicalSmiles":"Cc1cnc(C(=O)O)c[n+]1[O-]","inchiKey":"DJQOOSBJCLSSEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACIPIMOX","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olbetam"],"synonyms":["Acipimox"],"crossReferences":{"PubChem":["144205421","144206051","144206358","50110108"],"Wikipedia":["Acipimox"],"drugbank":["DB09055"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL346235","canonicalSmiles":"CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1.Cl.Cl","inchiKey":"FZNXAQMQVKBXDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMTHAZOLE DIHYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1184360","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," United States"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1972},"tradeNames":[],"synonyms":["Diamthazole dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France and  United States initially in 1972 due to Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL3542310","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/[14CH]=C2\\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O","inchiKey":"LBWFXVZLPYTWQI-LJHXPVAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542310","maximumClinicalTrialPhase":0,"parentId":"CHEMBL535","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544952","drugType":"Small molecule","blackBoxWarning":false,"name":"RG3487","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEM 3454","MEM-3454","MEM3454","RG-3487","RG3487","Rg3487"],"count":2,"linkedTargets":{"rows":["ENSG00000175344","ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":6},"linkedDiseases":{"rows":["EFO_0000249","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544989","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VOLANESORSEN SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 304801","ISIS 304801 SODIUM SALT","ISIS-304801 SODIUM","ISIS-304801 SODIUM SALT","Volanesorsen sodium","salt"],"count":1,"linkedTargets":{"rows":["ENSG00000110245"],"count":1},"linkedDiseases":{"rows":["EFO_1000727"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545007","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7602","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0425","RG-7602","Rg-7602"],"count":1,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545175","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03882845","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-3882845","Pf-03882845"],"count":2,"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3546271","canonicalSmiles":"Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1","inchiKey":"GETAAWDSFUCLBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORTAUCIPIR","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flortaucipir","T-807","T807"],"crossReferences":{"DailyMed":["flortaucipir%20f-18"],"drugbank":["DB15033"]},"childChemblIds":["CHEMBL3545253"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and has 1 investigational indication."}
{"id":"CHEMBL354634","canonicalSmiles":"COc1cc[nH]c1/C=C1\\C(=O)Nc2ccc(F)c(C#C[C@@H](O)[C@@H](N)[C@@H](C)O)c21","inchiKey":"RAKYKJWUUUKCCW-MPLBGYFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL354634","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03737"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL371491","canonicalSmiles":"CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2O)n1","inchiKey":"ZSOXFJURLPCSOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371491","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08395"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372396","canonicalSmiles":"CC(C)CCO","inchiKey":"PHTQWCKDNZKARW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLBUTANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212676"],"Wikipedia":["Isoamyl_alcohol"],"drugbank":["DB02296"],"chEBI":["15837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL373742","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"KBZOIRJILGZLEJ-LGYYRGKSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VASOPRESSIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beta-Hypophamine","Leiormone","Pitressin","Vasophysin","Vasostrict"],"synonyms":["Arginine Vasopressin","Arginine vasopressin","Vasopressin","Vasopressin injection"],"crossReferences":{"DailyMed":["vasopressin"],"PubChem":["144206588","29218064"],"chEBI":["34543"]},"childChemblIds":["CHEMBL2360839"],"count":16,"approvedIndications":["HP_0100806","MONDO_0004782"],"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148","ENSG00000198049"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003756","MONDO_0005149","EFO_0003777","EFO_0006834","MONDO_0002009","HP_0001919","MONDO_0003061","EFO_0005207","EFO_0004278","EFO_0003758","EFO_0003843","MP_0001914","MONDO_0004782","MONDO_0001572","HP_0003270","HP_0031273","EFO_0009492","EFO_0009637","EFO_0005251"],"count":20},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for diabetes insipidus and sepsis and has 14 investigational indications."}
{"id":"CHEMBL37390","canonicalSmiles":"CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"KYHQZNGJUGFTGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROXYPHYLLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thean"],"synonyms":["Proxyphylline"],"crossReferences":{"PubChem":["144204022","170465953","855655"],"Wikipedia":["Proxyphylline"],"drugbank":["DB13449"]},"count":1,"approvedIndications":["HP_0006536"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL376632","canonicalSmiles":"Cc1cc(N2CCC[C@@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1","inchiKey":"LBCGUKCXRVUULK-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3769414","canonicalSmiles":"CN1C(=O)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12","inchiKey":"BBIPVJCGIASXJB-PKTZIBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3769414","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15039"]},"childChemblIds":["CHEMBL3770459"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833335","canonicalSmiles":"C[N+](C)(C)CC(=O)[O-].OC(O)C(Cl)(Cl)Cl","inchiKey":"ONAOIDNSINNZOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAL BETAINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["5107","Chloral betaine","Cloral betaine"],"crossReferences":{"drugbank":["DB01494"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL388590","canonicalSmiles":"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1","inchiKey":"WHQCHUCQKNIQEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZBROMARONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desuric","Narcaricin mite"],"synonyms":["Benzbromaron","Benzbromarone","L-2214","MJ 10061","MJ-10061","NSC-85433"],"crossReferences":{"PubChem":["11110651","122758","144203592","170465792","24424558","26664708","4253342","50103990","56422114","855676"],"TG-GATEs":["21"],"Wikipedia":["Benzbromarone"],"drugbank":["DB12319"],"chEBI":["3023"]},"count":3,"approvedIndications":["EFO_0004274"],"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["Orphanet_275766","EFO_0009104","EFO_0004274"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gout and has 2 investigational indications."}
{"id":"CHEMBL398338","canonicalSmiles":"CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2[nH]ncc12","inchiKey":"TYOYXJNGINZFET-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-102","Abt-102"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989566","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"BRIPGNJWPCKDQZ-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPROLOL FUMARATE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lopressor","Metoros","Metoros ls"],"synonyms":["CGP 2175C","Metoprolol fumarate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL3989585","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.O=S(=O)(O)O","inchiKey":"JBBINZRUTLUBFR-NRGUFEMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROMORPHONE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL398707","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydromorphone sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989926","canonicalSmiles":"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1","inchiKey":"WLAVZAAODLTUSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITRAVATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MG-516","MG-91516","MGCD-516","MGCD516","Sitravatinib"],"crossReferences":{"drugbank":["DB15036"]},"childChemblIds":["CHEMBL4298164"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3990040","drugType":"Gene","blackBoxWarning":false,"name":"NALOTIMAGENE CARMALEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HSV-TK","Nalotimagene carmaleucel"],"count":3,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4062002","canonicalSmiles":"[2H]C1([2H])CC([2H])([2H])C12C(=O)N(c1cnc(C#N)c(C(F)(F)F)c1)C(=S)N2c1ccc(C(=O)NC)c(F)c1","inchiKey":"HJBWBFZLDZWPHF-NZLXMSDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4062002","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3183409","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408701","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QBYUNVOYXHFVKC-GBURMNQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROLITHOCHOLIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taurolithocholate","Taurolithocholic acid","Tauroursodeoxycholic acid"],"crossReferences":{"chEBI":["36259"]},"childChemblIds":["CHEMBL2028239"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4094396","canonicalSmiles":"CNC(C)C(=O)c1ccc(C)cc1","inchiKey":"YELGFTGWJGBAQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHEDRONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.756.280I","Mephedrone"],"crossReferences":{"drugbank":["DB13108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4204869","canonicalSmiles":"C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12","inchiKey":"AACUJFVOHGRMTR-DPXNYUHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELENBECESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-2609","E2609","Elenbecestat"],"crossReferences":{"drugbank":["DB15391"]},"count":1,"linkedTargets":{"rows":["ENSG00000186318"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL427896","canonicalSmiles":"C[C@@H]1CN(c2ccc([N+](=O)[O-])cc2)CCN1S(=O)(=O)c1ccc(C(C)(C)C)cc1","inchiKey":"SOFGQQQVQZQJFS-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL427896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07049"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428593","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)OCC(O)CO","inchiKey":"RZRNAYUHWVFMIP-KTKRTIGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL MONOOLEATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glyceryl monooleate"],"crossReferences":{"drugbank":["DB13171"],"chEBI":["75342"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297274","canonicalSmiles":"CCCCCCCCCCCCNCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"MZNMZWZGUGFQJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-2584","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT 2584","Ct-2584"],"crossReferences":{"drugbank":["DB13098"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297460","canonicalSmiles":"CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC","inchiKey":"QDZOBXFRIVOQBR-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CC-11050","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-11050","Cc-11050"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297501","canonicalSmiles":"Cc1c(CN(C)C(=O)/C=C/c2cnc3c(c2)CCC(=O)N3COP(=O)(O)O)oc2ccccc12","inchiKey":"HFYMDQMXVPJNTH-VQHVLOKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFABICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afabicin"],"crossReferences":{"drugbank":["DB15268"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297537","drugType":"Oligonucleotide","blackBoxWarning":true,"name":"INOTERSEN SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tegsedi"],"synonyms":["Inotersen sodium"],"crossReferences":{"DailyMed":["inotersen%20sodium"]},"count":1,"approvedIndications":["Orphanet_85447"],"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["Orphanet_85447"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for familial amyloid polyneuropathy. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297678","canonicalSmiles":"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](OCC(C)O)[C@@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1C[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)O[C@@H]3CO","inchiKey":"NJWCVQBHNBLNOZ-ZRMYETLXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ADRABETADEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrabetadex","VT-270","VTS-270","Vts-270"],"crossReferences":{"drugbank":["DB15146"]},"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297699","drugType":"Protein","blackBoxWarning":false,"name":"BALIXAFORTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balixafortide","POL-6326"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297788","drugType":"Antibody","blackBoxWarning":false,"name":"MOSUNETUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTCT-4465A","BTCT4465A","Mosunetuzumab","RG-7828","RG7828","RO-7030816","RO7030816"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297862","drugType":"Unknown","blackBoxWarning":true,"name":"BOTULINUM TOXIN TYPE A","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Agn-151607","Ant-1401","Ant-1403","Botulift","Botulinum a toxin","Botulinum toxin type a","Btx-a","Cunox","Neuronox","RTI-150","RTI150"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297958","drugType":"Protein","blackBoxWarning":false,"name":"GLUCAGON-LIKE PEPTIDE II","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glp-2","Glucagon-like peptide 2","Glucagon-like peptide ii"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298005","drugType":"Unknown","blackBoxWarning":false,"name":"MITIGLINIDE CALCIUM DIHYDRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KAD-1229","Kad-1229","Mitiglinide calcium dihydrate","Mitiglinide calcium hydrate","Mitiglinide calcium salt dihydrate","S-21403"],"count":1,"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298088","drugType":"Antibody","blackBoxWarning":false,"name":"CETUXIMAB SAROTALOCAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetuximab sarotalocan","Cetuximab-IRDye-700DX","RM-1929"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0006859"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4298119","drugType":"Antibody","blackBoxWarning":false,"name":"OLINVACIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olinvacimab","TTAC-0001","Tanibirumab","Ttac-0001"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298191","drugType":"Antibody","blackBoxWarning":false,"name":"SASANLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06801591","RN-888","Sasanlimab"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4301492","canonicalSmiles":"COC(=O)[C@H]1[C@@H](c2ccc(F)cc2)C[C@@H]2CC[C@H]1N2C/C=C/I","inchiKey":"GTQLIPQFXVKRKJ-UNSMHXHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTROPANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Altropane","Iacft"],"crossReferences":{"drugbank":["DB04947"]},"childChemblIds":["CHEMBL4297407"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL435128","canonicalSmiles":"CC(C)c1nc(COC(N)=O)n(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1","inchiKey":"YQXCVAGCMNFUMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPRAVIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Capravirine","S-1153"],"crossReferences":{"Wikipedia":["Capravirine"],"drugbank":["DB08502"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL447955","canonicalSmiles":"C[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"FLNYCRJBCNNHRH-OIYLJQICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERLOPITANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0594","Serlopitant","VPD-737","Vpd-737"],"crossReferences":{"drugbank":["DB12973"]},"count":2,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0026045","EFO_1000690"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594294","canonicalSmiles":"CNCC1CCCCN1C(=O)Oc1ccc(CNC(=O)CCCC/C=C/C(C)C)cc1OC","inchiKey":"BXAQOVOOXOHMFY-YRNVUSSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOCACAPSAICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CA-008","Ca-008","Vocacapsaicin"],"childChemblIds":["CHEMBL4594295"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594309","drugType":"Gene","blackBoxWarning":false,"name":"ORVACABTAGENE AUTOLEUCEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JCARH-125","JCARH125","Jcarh125","Orvacabtagene autoleucel"],"count":1,"description":"Gene drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594565","drugType":"Protein","blackBoxWarning":false,"name":"PABINAFUSP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JR-141","Jr-141","Pabinafusp alfa"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL462019","canonicalSmiles":"O=P1(N(CCCl)CCCl)OCCCN1CCCl","inchiKey":"UMKFEPPTGMDVMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-4828","NSC-109723","Trofosfamide","Trophosphamide","Z-4828"],"crossReferences":{"PubChem":["92764496"],"Wikipedia":["Trofosfamide"],"drugbank":["DB12902"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL466465","canonicalSmiles":"Cc1ccc(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)cc1","inchiKey":"RDFCSSHDJSZMTQ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Tosyl-L-Lysine Chloromethyl Ketone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tosyl-L-Lysine Chloromethyl Ketone"],"crossReferences":{"PubChem":["11111912","50111259"],"drugbank":["DB08603"],"chEBI":["9640"]},"childChemblIds":["CHEMBL1256974"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46730","canonicalSmiles":"c1ccc2c(c1)ccc1ccccc12","inchiKey":"YNPNZTXNASCQKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENANTHRENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-26256","Phenanthrene"],"crossReferences":{"PubChem":["144208836","144210890","17388787","26752927","85272564"],"chEBI":["28851"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47298","canonicalSmiles":"CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2","inchiKey":"MPMFCABZENCRHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILORONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amixin IC","Tilorone"],"crossReferences":{"PubChem":["144205037","170466150","26749100"],"Wikipedia":["Tilorone"]},"childChemblIds":["CHEMBL539581"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL477786","canonicalSmiles":"Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)n2)n1C(C)C","inchiKey":"PVTKDXZNSUHUMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL477786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483091","canonicalSmiles":"CC(C)SC(=N)N","inchiKey":"XSSNABKEYXKKMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Isopropyl-Isothiourea","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Isopropyl-Isothiourea"],"crossReferences":{"PubChem":["11113769"],"drugbank":["DB04018"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489285","canonicalSmiles":"O=C(Nc1cc(Br)c(O)c(Br)c1)c1cc(Cl)ccc1Cl","inchiKey":"IFLWCZRMFPKYBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489285","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07694"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49120","canonicalSmiles":"CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1","inchiKey":"IFPPYSWJNWHOLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0166285","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-0166285","TCMDC-140940"],"crossReferences":{"PubChem":["103905313","137275855","307078458"]},"childChemblIds":["CHEMBL3545196"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL50300","canonicalSmiles":"O=C(O)CP(=O)(O)O","inchiKey":"XUYJLQHKOGNDPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFONET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfonet"],"crossReferences":{"PubChem":["11110652","124878320","144203596","170466274","4253808","50106880","8139976","85230868","90341376"],"drugbank":["DB02823"],"chEBI":["15732"]},"childChemblIds":["CHEMBL136061","CHEMBL2028559","CHEMBL3989828"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL514794","canonicalSmiles":"Cc1cc(CNC(=O)c2cc(C(=O)NCc3ccc(F)c(C)c3)ncn2)ccc1F","inchiKey":"PYFRREJCFXFNRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL514794","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04760"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL53","canonicalSmiles":"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3","inchiKey":"VMWNQDUVQKEIOC-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APOMORPHINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["APL-130277","Apomorphine","VR-040","VR040"],"crossReferences":{"DailyMed":["apomorphine%20hydrochloride"],"PubChem":["11114270","144204518","170465297","26752261"],"Wikipedia":["Apomorphine"],"drugbank":["DB00714"],"chEBI":["48538"]},"childChemblIds":["CHEMBL3187985","CHEMBL1256708","CHEMBL1616"],"count":5,"approvedIndications":["EFO_0002508","EFO_0004234"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002508","EFO_0004234","HP_0003419","MONDO_0043510","EFO_0003882","EFO_0003829","HP_0000738"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for parkinson's disease and erectile dysfunction and has 3 investigational indications."}
{"id":"CHEMBL549695","canonicalSmiles":"Cc1ccc(N)cc1C(=O)N[C@H](C)c1cccc2ccccc12","inchiKey":"UVERBUNNCOKGNZ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549695","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559147","canonicalSmiles":"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1","inchiKey":"IYOZTVGMEWJPKR-IJLUTSLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Y-27632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Y-27632"],"crossReferences":{"PubChem":["26753164","26753165"],"drugbank":["DB08756"],"chEBI":["75393"]},"childChemblIds":["CHEMBL1605605"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559362","canonicalSmiles":"Br.O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O","inchiKey":"SJUWEPZBTXEUMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOFUGINONE HYDROBROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1197091","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stenorol"],"synonyms":["Halofuginone hydrobromide","RU-19110"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL561540","canonicalSmiles":"O=C1/C(=N\\O)c2c(/C=C/c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2","inchiKey":"DDHASJXGNUWZTM-ZLEWNXFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561540","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08010"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56279","canonicalSmiles":"N#CN","inchiKey":"XZMCDFZZKTWFGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYANAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyanamide"],"crossReferences":{"PubChem":["144210995","26757797"],"Wikipedia":["Cyanamide"],"drugbank":["DB02679"],"chEBI":["16698"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566","canonicalSmiles":"O=c1cc[nH]c(=O)[nH]1","inchiKey":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-205603-01","Fluorouracil specified compound c","Lamivudine impurity e","Lamivudine impurity e rs","NSC-3970","SQ-6201","SQ-7726","SQ-8493","Uracil"],"crossReferences":{"PubChem":["144208221","170465915","51088798","70371"],"Wikipedia":["Uracil"],"drugbank":["DB03419"],"chEBI":["17568"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL567303","canonicalSmiles":"Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1","inchiKey":"WYJCYXOCHXWTHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOSURAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Act-058362","Palosuran"],"childChemblIds":["CHEMBL1164032"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL59","canonicalSmiles":"NCCc1ccc(O)c(O)c1","inchiKey":"VYFYYTLLBUKUHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOPAMINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbilev","Dopamine","Intropin","NSC-173182","Parcopa","Sinemet"],"crossReferences":{"DailyMed":["dopamine%20hydrochloride"],"PubChem":["104171172","11111282","124880336","124880337","124880340","144203718","170464942","26750067","26753786","26753787","50107800","57288369","90341661"],"Wikipedia":["Dopamine"],"drugbank":["DB00988"],"chEBI":["18243"]},"childChemblIds":["CHEMBL3247442","CHEMBL1557"],"count":8,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0006859","EFO_0006834","EFO_0002508","EFO_0005207","EFO_0000319","HP_0100806","HP_0100543","MONDO_0002050","EFO_1001485","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0003917","HP_0031273","EFO_0000400","EFO_0005251","EFO_1000899"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for cardiovascular disease and has 7 investigational indications."}
{"id":"CHEMBL591","canonicalSmiles":"C#CC(O)(/C=C/Cl)CC","inchiKey":"ZEHYJZXQEQOSON-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHCHLORVYNOL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethchlorvynol","Placidyl"],"synonyms":["Ethchlorvynol"],"crossReferences":{"Wikipedia":["Ethchlorvynol"],"drugbank":["DB00189"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL657","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1","inchiKey":"ZZVUWRFHKOJYTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antitussive","Beldin","Belix","Benadryl","Benylin","Dibenil","Diphen","Diphenhydramine","Hydramine","Silphen"],"crossReferences":{"DailyMed":["diphenhydramine%20citrate","diphenhydramine%20hydrochloride"],"PubChem":["104171144","11111059","11111060","124879862","124879863","144203678","170466857","26751623","50100219","50104292","85148365","90341811"],"Wikipedia":["Diphenhydramine"],"drugbank":["DB01075"],"chEBI":["4636"]},"childChemblIds":["CHEMBL1620","CHEMBL1201089"],"count":47,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0002610","MONDO_0002009","EFO_0005592","HP_0012735","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000540","HP_0002018","EFO_0003829","Orphanet_365","EFO_0000096","EFO_0000544","EFO_0002690","MONDO_0008903","EFO_0000692","EFO_1001904","EFO_0005854","EFO_0005761","EFO_0000220","EFO_0003821","EFO_0000384","MONDO_0008315","EFO_0004239","MP_0001845","EFO_0009688","Orphanet_60","MONDO_0044917","EFO_0000574","EFO_0001378","EFO_0003785","EFO_0003086","HP_0000726","EFO_0005252","MONDO_0007254","EFO_0000274","MONDO_0020657","MONDO_0001056","EFO_1000783","EFO_0005531","MONDO_0002050","EFO_0006890","EFO_0003938","HP_0002013","EFO_0005230","EFO_0007490","EFO_0000616","EFO_0000685","EFO_0008521","EFO_0000403","EFO_0003843","HP_0002315","EFO_0003060","EFO_0004599","EFO_0000311","EFO_0000095","EFO_0007359","MONDO_0011962","MONDO_0002367","EFO_0004270"],"count":61},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for pruritus and allergy and has 45 investigational indications."}
{"id":"CHEMBL6607","canonicalSmiles":"COc1cc(CC(C)N)c(OC)cc1Br","inchiKey":"FXMWUTGUCAKGQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROLAMFETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brolamfetamine"],"crossReferences":{"Wikipedia":["2,5-Dimethoxy-4-bromoamphetamine"],"drugbank":["DB01484"]},"childChemblIds":["CHEMBL2355922"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6731","canonicalSmiles":"CC(N)Cc1ccc2c(c1)OCO2","inchiKey":"NGBBVGZWCFBOGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENAMFETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenamfetamine"],"crossReferences":{"Wikipedia":["3,4-Methylenedioxyamphetamine"],"drugbank":["DB01509"]},"childChemblIds":["CHEMBL3186623"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL73502","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](CO)C[C@H]2O)c(=O)[nH]1","inchiKey":"OROIAVZITJBGSM-OBXARNEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3'-Deoxyguanosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-Deoxyguanosine"],"crossReferences":{"drugbank":["DB03609"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL891","canonicalSmiles":"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"LQOLIRLGBULYKD-JKIFEVAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOXACILLIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orbenin"],"synonyms":["Cloxacillin","Cloxapen","Tegopen"],"crossReferences":{"Wikipedia":["Cloxacillin"],"drugbank":["DB01147"],"chEBI":["49566"]},"childChemblIds":["CHEMBL3989531","CHEMBL1200388","CHEMBL262636"],"count":5,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL90403","canonicalSmiles":"O=C(O)[C@@H](CS)Cc1ccccc1","inchiKey":"ZUEBVBPVXLQMQR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL90403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02953"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
